title: [Use of lornoxicam for analgesia in the early postoperative period].
abstract: Lornoxicam was used for analgesia in 64 patients on days 1-2 after extensive interventions. The drug efficiency and safety were evaluated depending on the dose and route of administration. Intravenous infusion of lornoxicam in a daily dose of 24 mg (basic therapy) did not involve the use of opioids in 35% patients and its analgesic effect was higher than that of promedol monotherapy. Combined therapy with lornoxicam and promedol allows reduction of promedol dose by 25-50% and the incidence of untoward effects by 27-44%.
authors.forename: V V
authors.initials: VV
authors.lastname: Nikoda
authors.forename: R B
authors.initials: RB
authors.lastname: Maiachkin
authors.forename: A V
authors.initials: AV
authors.lastname: Bondarenko
authors.forename: Iu E
authors.initials: IuE
authors.lastname: Mikhaĭlov
authors.forename: N P
authors.initials: NP
authors.lastname: Anosova
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010149:Postoperative Pain / Q000188:drug therapy*; D010894:Piroxicam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011396:Promedol / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; D011396:Promedol; C059451:lornoxicam